Diabetes Research and Clinical Practice: Published on December, 2022Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors also called gliflozins are a class of medicine used to lower high blood glucose levels in people with type 2 diabetes. Medicines in the SGLT2 inhibitor class include Canagliflozin, Dapagliflozin, Empagliflozin, Ertugli...

AHA Journal: Circulation: Published on February, 2023Low-density lipoprotein cholesterol (LDL-C) level is a well-established risk factor for atherosclerotic cardiovascular disease. However, the optimal achieved LDL-C level with regard to efficacy and safety in the long term remains unknown.TAKE-HOME MESSAGEThis study assessed the relationship...

JAMA Cardiology: Published on June, 2022 TAKE-HOME MESSAGE Question: Is starting cardiac rehabilitation exercise training 2 weeks after sternotomy as effective and safe as starting 6 weeks after sternotomy? Findings: In this assessor-blind, noninferiority, randomized clinical trial of 158 cardiac surgery patients, starting cardiac...

Paracetamol has often been cited as a safer alternative to non-steroidal anti-inflammatory drugs (NSAIDs) with regards blood pressure and cardiovascular health. But now researchers have raised concerns about this, suggesting that those taking paracetamol long-term may be at greater risk of heart attack and stroke.Long-term paracetamol use could...

Worldwide, cardiovascular diseases (CVDs) Source are one of the leading causes of death. Every year, an estimated 17.9 million people around the world die as a result of complications from heart diseases. For context, this means that CVDs are responsible for 32% of all deaths globally.Prior studies Source show that various factors — such as se...